DISCOUNT OPTIONSSCHEIN - NOVO NORDISK ADR B | Market Closed - Boerse Frankfurt Warrants 11:33:18 31/05/2024 pm IST | ||
| 1.05 EUR | -.--% |
|
| 1 month | -11.02% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
More news
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 1.05 | -.--% |
| 30/24/30 | 1.05 | -0.94% |
| 29/24/29 | 1.06 | -.--% |
| 28/24/28 | 1.06 | +0.95% |
| 27/24/27 | 1.05 | +5.00% |
Real-time Boerse Frankfurt Warrants
Last update May 31, 2024 at 11:33 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | PUT |
| Underlying | NOVO NORDISK A/S |
| Issuer | 
Vontobel
|
| WKN | VD3WR1 |
| ISIN | DE000VD3WR13 |
| Date issued | 10/04/2024 |
| Strike | 150 $ |
| Maturity | 21/03/2025 (292 Days) |
| Parity | 10 : 1 |
| Emission price | 1.13 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.31 € |
|---|---|
| Lowest since issue | 0.99 € |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
927.3
DKK
Average target price
917.2
DKK
Spread / Average Target
-1.09%
- Stock Market
- Certificates
- Certificat
